Personalized Medicine Plus Diagnostics Equals Profits for Investors

By Tony Daltorio – July 20, 2012 | Tickers: A, BMY, LLY, QGEN, RHHBY.PK | 0 Comments Tony is a member of The Motley Fool Blog Network — entries represent the personal opinions of our bloggers and are not formally edited. Nearly every investor has heard about the patent cliff facing the major pharmaceutical companies. But there is another, quiet revolution occurring in the pharmaceutical sector right nowwhich very well may change its current business model drastically. Continue reading